SCHEMBL7011173

SCHEMBL7011173

Cc1cc(F)ccc1[CH]c1ccccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 2/20 0.41
MAPT P10636 5/20 0.40
RAB9A P51151 3/20 0.40
NPC1 O15118 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
HSD11B1 P28845 1/20 0.39
ALDH1A1 P00352 1/20 0.38
PDE2A O00408 1/20 0.37
PDE10A Q9Y233 1/20 0.37
RXFP1 Q9HBX9 1/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP1B1 Q16678 1/20 0.36
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
KCNH2 Q12809 1/20 0.35
POLB P06746 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3301954 0.74 ALDH1A1 (0.62) NFE2L2HPGDALDH1A1CYP1A1CYP1A2
SCHEMBL6935115 0.74 ALDH1A1 (0.45) NFE2L2MAPTNPC1HTTALDH1A1
SCHEMBL2089900 0.72 NFE2L2 (0.47) NFE2L2MAPTRAB9ANPC1SMN1; SMN2
SCHEMBL27686167 0.70 TDP1 (0.54) MAPTRAB9ANPC1SMN1; SMN2HPGD
SCHEMBL11410638 0.69 MAPT (0.46) NFE2L2MAPTRAB9ANPC1SMN1; SMN2
SCHEMBL11406154 0.69 MAPT (0.56) NFE2L2MAPTRAB9ANPC1SMN1; SMN2
SCHEMBL11410654 0.69 MAPT (0.46) NFE2L2MAPTRAB9ANPC1SMN1; SMN2
SCHEMBL600882 0.68
SCHEMBL11410428 0.68 MAPT (0.57) NFE2L2MAPTRAB9ANPC1SMN1; SMN2
SCHEMBL867378 0.67 PTGS2 (0.41) NFE2L2HTR2AHTR2CKCNH2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1268450-A1 LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF A-BETA PROTEIN PRODUCTION Bristol-Myers Squibb Pharma Company (US) 2003-01-02 EP disclosed
WO-2001092235-A1 LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-12-06 WO disclosed